These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4510091)

  • 21. Iatrogenesis imperfecta.
    Friedman JH
    Med Health R I; 2002 Jul; 85(7):198. PubMed ID: 12182087
    [No Abstract]   [Full Text] [Related]  

  • 22. Mania secondary to procyclidine ("Kemadrin") abuse.
    Coid J; Strang J
    Br J Psychiatry; 1982 Jul; 141():81-4. PubMed ID: 7116076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiparkinson drugs used as prophylactics for nerve agents: studies of cognitive side effects in rats.
    Myhrer T; Enger S; Aas P
    Pharmacol Biochem Behav; 2008 Jun; 89(4):633-8. PubMed ID: 18384867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined intramuscular administration of depot fluphenazine and benztropinemesylate in chronic schizophrenic patients.
    Bucci L
    Curr Ther Res Clin Exp; 1971 Aug; 13(8):545-8. PubMed ID: 4999204
    [No Abstract]   [Full Text] [Related]  

  • 25. Involvement of serotonin in clinical features of Parkinson's disease and complications of L-DOPA therapy.
    Melamed E; Zoldan J; Friedberg G; Ziv I; Weizmann A
    Adv Neurol; 1996; 69():545-50. PubMed ID: 8615179
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacology in the elderly: psychological and physiological interrelationships.
    Hooyman NW; Gambert SR
    Psychiatr Med; 1983 Dec; 1(4):445-58. PubMed ID: 6152848
    [No Abstract]   [Full Text] [Related]  

  • 27. [Psychoses in chronic ephedrine addiction].
    Eggert Hansen C
    Nord Med; 1968 Nov; 80(46):1545-9. PubMed ID: 5706259
    [No Abstract]   [Full Text] [Related]  

  • 28. Clozapine treatment of psychosis in patients with Parkinson's disease.
    Friedman JH
    J Clin Psychiatry; 1994 Feb; 55(2):79. PubMed ID: 8077160
    [No Abstract]   [Full Text] [Related]  

  • 29. The stereochemical basis of anticonvulsant drug action. 3. The structure of procyclidine hydrochloride.
    Camerman N; Camerman A
    Mol Pharmacol; 1971 Jul; 7(4):406-12. PubMed ID: 5113235
    [No Abstract]   [Full Text] [Related]  

  • 30. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?
    Neu C; Dimascio A; Demirgian E
    Curr Ther Res Clin Exp; 1972 May; 14(5):246-51. PubMed ID: 4623975
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of antidepressant drugs on the urinary tract. Clinical and animal studies.
    Feaver BD; Usher M; MacEwan DW
    J Can Assoc Radiol; 1967 Dec; 18(4):442-7. PubMed ID: 6080022
    [No Abstract]   [Full Text] [Related]  

  • 32. High dosage chlorpromazine alone and in combination with an antiparkinsonian agent (procyclidine) in the treatment of hospitalized depressions.
    Raskin A
    J Nerv Ment Dis; 1968 Aug; 147(2):184-95. PubMed ID: 4877904
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug-induced psychosis in Parkinson disease: phenomenology and correlations among psychosis rating instruments.
    Papapetropoulos S
    Clin Neuropharmacol; 2006; 29(1):59. PubMed ID: 16518136
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical features of cannabis psychosis in schizophrenia patients].
    Kenchadze VG; Chkoniia ED
    Georgian Med News; 2006 Aug; (137):55-8. PubMed ID: 16980745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Malignant neuroleptic syndrome].
    Bjørndal N; Remvig J; Gottlieb P
    Ugeskr Laeger; 1983 Feb; 145(8):570-3. PubMed ID: 6134367
    [No Abstract]   [Full Text] [Related]  

  • 36. Pramipexole-induced psychosis in Parkinson's disease.
    Li CT; Tsai SJ; Hwang JP
    Psychiatry Clin Neurosci; 2008 Apr; 62(2):245. PubMed ID: 18412854
    [No Abstract]   [Full Text] [Related]  

  • 37. Loxapine: a six-month evaluation in severely ill schizophrenic patients.
    Gallant DM; Bishop G; Steel CA; Bishop MP
    Curr Ther Res Clin Exp; 1973 Apr; 15(4):205-9. PubMed ID: 4633281
    [No Abstract]   [Full Text] [Related]  

  • 38. [Neuroleptic malignant syndrome-like state in eight patients with parkinsonism].
    Fujitake J; Kuno S; Nishitani H
    Rinsho Shinkeigaku; 1984 Apr; 24(4):371-8. PubMed ID: 6744760
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of Parkinson's disease and extrapyramidal syndromes with classical drugs (what can be expected from them in the levodopa era and which should be used)].
    Sigwald J
    Therapeutique; 1972 Nov; 48(9):561-8. PubMed ID: 4650525
    [No Abstract]   [Full Text] [Related]  

  • 40. 1-(3-Hydroxycyclohexyl)-1-phenyl-3-(1-pyrrolidinyl)-1-propanol, a procyclidine metabolite.
    Paeme G; Sonck W; Tourwé D; Grimée R; Vercruysse A
    Drug Metab Dispos; 1980; 8(2):115-6. PubMed ID: 6103784
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.